Biotechnology and Its Applications: Comprehensive Study Guide

Overview and Research Areas of Biotechnology

  • Definition and Scope: Biotechnology deals with the industrial-scale production of biopharmaceuticals and biologicals utilizing genetically modified microbes, fungi, plants, and animals.
  • Applications Spectrum: Key applications of biotechnology include:
    • Therapeutics
    • Diagnostics
    • Genetically modified (GM) crops for agriculture
    • Processed food
    • Bioremediation
    • Waste treatment
    • Energy production
  • Three Critical Research Areas of Biotechnology:
    1. Providing the Best Catalyst: Obtaining or creating an improved organism, usually a microbe or a pure enzyme, to act as an optimal biological catalyst.
    2. Creating Optimal Conditions: Developing engineering parameters and optimal environment for the biological catalyst to function efficiently.
    3. Downstream Processing Technologies: Establishing purification methodologies to isolate and refine the targeted protein or organic compound.

Biotechnological Applications in Agriculture

Methods for Increasing Food Yields

  • Three Approaches to Agricultural Production:
    1. Agro-chemical based agriculture.
    2. Organic agriculture.
    3. Genetically engineered crop-based agriculture.
  • The Green Revolution:
    • Successfully tripled the global food supply, but proved insufficient to meet the needs of the exponentially growing human population.
    • Increased crop yields were partially due to improved crop varieties, but primarily resulted from improved management practices and heavy use of agrochemicals (chemical fertilizers and synthetic pesticides).
    • Limitations: Agrochemicals are prohibitively expensive for farmers in the developing world. Furthermore, further yield increases using conventional breeding techniques have reached a plateau.

Plant Tissue Culture and Somatic Hybridisation

  • Tissue Culture: Developed as a rapid, highly efficient alternative to conventional plant breeding.
    • Explant: Any part of a plant taken out and grown in a test tube under sterile (aseptic) conditions in a specialized nutrient medium.
    • Totipotency: The cellular capacity of an explant or any plant cell to regenerate into an entire, whole plant.
    • Nutrient Medium Requirements: Must contain a carbon source (e.g., sucrose), inorganic salts, vitamins, amino acids, and plant growth regulators (e.g., auxins, cytokinins).
    • Micro-propagation: The method of mass-producing thousands of plants in very short durations using tissue culture techniques.
    • Somaclones: Plants produced via micro-propagation that are genetically identical to each other and to the original parent plant from which they were derived. Commercial applications include tomato, banana, and apple.
  • Recovery of Virus-Free Plants:
    • Even if an entire plant is infected with a virus, the meristem (both apical and axillary) remains virus-free.
    • Culturing the meristem in vitro allows for the recovery of healthy, virus-free plants. Successfully achieved in banana, sugarcane, and potato.
  • Somatic Hybridisation:
    • Protoplast Isolation: Single cells isolated from plant tissue have their cell walls digested enzymatically, yielding naked protoplasts enclosed only by plasma membranes.
    • Protoplast Fusion: Isolated protoplasts from two distinct varieties of plants (each possessing desirable characteristics) are fused to yield a hybrid protoplast.
    • Somatic Hybrids: Plants regenerated from fused hybrid protoplasts. The process is termed somatic hybridisation.
    • The Pomato Example: A somatic hybrid created by fusing protoplasts of tomato and potato plants. Although successfully regenerated, the pomato lacked the full combination of commercially desirable traits required for widespread economic utilization.

Genetically Modified Organisms (GMOs)

  • Definition: Plants, bacteria, fungi, and animals whose genetic material has been manipulated and altered artificially are defined as Genetically Modified Organisms.
  • Advantages of GM Crops:
    • Abiotic Stress Tolerance: Enhanced resilience against environmental stresses such as cold, drought, salt, and extreme heat.
    • Pest Resistance: Reduced reliance on chemical pesticides by incorporating built-in pest defense.
    • Reduced Post-Harvest Losses: Improved shelf-life and structural integrity during storage and transport.
    • Improved Mineral Efficiency: Enhanced efficiency of mineral usage prevents premature depletion of soil fertility.
    • Enhanced Nutritional Value: Biofortification of crops, such as Golden Rice (a Vitamin 'A'-enriched rice variety).
  • Industrial Applications: Creation of tailor-made crops to supply bio-based industrial feedstock, including starches, biofuels, and pharmaceuticals.

Pest-Resistant Plants and Bt Technology

  • Bt Toxin Mechanism:
    • Bacillus thuringiensis (Bt) produces specific protein crystals during a specific phase of its growth cycle containing toxic insecticidal proteins.
    • Target insect orders include:
      • Lepidopterans: Tobacco budworm, armyworm.
      • Coleopterans: Beetles.
      • Dipterans: Flies, mosquitoes.
    • Inactivity in Bacteria: The Bt toxin protein exists within the bacterium as an inactive precursor called a protoxin, which rendered it harmless to the host bacterium itself.
    • Activation in Insects: When an insect ingests the protoxin, the alkaline pH of the insect midgut solubilizes the protein crystals. Solubilization converts the inactive protoxin into its active form.
    • Pathology: The activated toxin binds specifically to the surface of midgut epithelial cells, forming pores that cause osmotic cell swelling, lysis, and ultimately the death of the insect pest.

Cotton boll destroyed by bollworms vs fully mature cotton boll

  • Bt Crop Engineering:
    • Specific Bt toxin genes are isolated from Bacillus thuringiensis and cloned into major crop species (e.g., Bt cotton, Bt corn, rice, tomato, potato, soybean).
    • Gene Specificity: Bt toxins are insect-group specific. The toxin gene is designated as cry.
      • cryIAc and cryIIAb: Encode proteins that control cotton bollworms.
      • cryIAb: Encodes a protein that controls the corn borer.

Pest Resistance via RNA Interference (RNAi)

  • Nematode Infection: The nematode Meloidogyne incognita infects the root system of tobacco plants, causing severe root damage and substantial reductions in crop yield.
  • Mechanism of RNA Interference (RNAi):
    • RNAi functions as a biological cellular defense mechanism present in all eukaryotic organisms.
    • Involves the post-transcriptional silencing of a specific target mRNA molecule by a complementary double-stranded RNA (dsRNA) molecule that binds to the mRNA and prevents its translation.
    • Sources of Complementary dsRNA: Can originate from viral infections possessing RNA genomes or from mobile genetic elements called transposons that replicate via an RNA intermediate.

Host plant-generated dsRNA triggers protection against nematode infestation

  • Transgenic Application in Tobacco:
    1. Nematode-specific genes are introduced into the host tobacco plant using Agrobacterium vectors.
    2. The inserted DNA is configured to produce both sense and anti-sense RNA strands in host plant cells.
    3. Because these two RNA strands are complementary, they pair to form double-stranded RNA (dsRNA).
    4. The host dsRNA initiates the RNAi pathway, silencing the targeted mRNA of the invading nematode.
    5. The parasite cannot survive in the transgenic host expressing specific interfering RNA, granting full protection to the plant.

Biotechnological Applications in Medicine

Recombinant Therapeutics

  • Impact: Recombinant DNA technology enables mass production of safe, pure, and highly effective human therapeutic proteins.
  • Immunological Advantage: Unlike therapeutics isolated from animal or non-human tissue, recombinant human proteins do not trigger unwanted, adverse hyper-immunological reactions.
  • Global Status: Approximately 30 recombinant therapeutics have been approved for human use worldwide; 12 of these are currently marketed in India.

Genetically Engineered Human Insulin

  • Historical Context: Diabetic management requires regular injections of insulin. Insulin was previously harvested from the pancreas of slaughtered cattle and pigs. Animal-derived insulin frequently induced allergic responses and immune reactions due to foreign protein sequence variations.
  • Structural Composition of Human Insulin:
    • Consists of two short polypeptide chains: Chain A and Chain B.
    • Chain A and Chain B are covalently linked together by disulphide bridges.

Maturation of pro-insulin into insulin

  • Pro-hormone Maturation:
    • In mammals, insulin is initially synthesized as an inactive precursor called pro-insulin (or a pro-hormone).
    • Pro-insulin contains an additional polypeptide segment called the C peptide.
    • During maturation, the C peptide is cleaved and removed, yielding mature functional insulin.
  • Production via Recombinant DNA Technology (1983):
    • The American company Eli Lilly chemically synthesized two separate DNA sequences corresponding to the A and B chains of human insulin.
    • These synthetic gene sequences were inserted into plasmids of Escherichia coli to produce Chain A and Chain B individually.
    • The individual chains were extracted from bacterial cultures and chemically joined in vitro by forming disulfide bonds to assemble functional human insulin.

Gene Therapy

  • Definition: A collection of corrective clinical techniques designed to repair or compensate for hereditary gene defects diagnosed in children or embryos by introducing functional normal genes into cells and tissues.
  • First Clinical Application (1990):
    • Administered to a 4-year-old girl suffering from Adenosine Deaminase (ADA) deficiency.
    • ADA is a critical enzyme required for proper metabolic development and functional maintenance of the human immune system.
    • ADA deficiency is caused by the genetic deletion of the gene coding for adenosine deaminase.
  • Alternative Interventions and Limitations:
    • Bone Marrow Transplantation: Effective in curing some affected children.
    • Enzyme Replacement Therapy: Direct periodic injection of functional ADA enzyme.
    • Limitation: Neither method provides a completely permanent cure.
  • Gene Therapy Protocol:
    1. Lymphocytes are isolated from the patient's peripheral blood and cultured in vitro.
    2. A functional cDNA copy of the human ADA gene is introduced into these cultured lymphocytes using a retroviral vector.
    3. The engineered, functional ADA-expressing lymphocytes are infused back into the patient.
    4. Requirement for Repeated Infusion: Because human lymphocytes possess a finite lifespan and are not immortal, patients require periodic infusions of genetically engineered cells.
  • Permanent Cure Strategy: Isolation of the functional ADA gene from bone marrow cells followed by its transfection into cells at early embryonic stages.

Molecular Diagnostics

  • Conventional Diagnostics: Standard techniques (e.g., serum chemistry, urinalysis) cannot detect pathogens or metabolic anomalies at low titers prior to the clinical manifestation of disease symptoms.
  • Advanced Recombinant Diagnostic Tools:
    • Polymerase Chain Reaction (PCR):
      • Enables rapid enzymatic amplification of specific target nucleic acid sequences (DNA or RNA).
      • Detects trace amounts of pathogen DNA/RNA when pathogen titers are extremely low and asymptomatic.
      • Routinely used to detect HIV infection in suspected AIDS patients, detect driver mutations in oncogenic cellular genes, and identify diverse genetic disorders.
    • Nucleic Acid Probes & Autoradiography:
      • A single-stranded DNA or RNA molecule tagged with a radioactive isotope label is used as a probe.
      • The probe is allowed to hybridize to its complementary sequence within cloned cell colonies.
      • Visualization via autoradiography shows normal genes; colonies carrying a mutated gene fail to bind the probe due to lost sequence complementarity and do not appear on the photographic film.
    • Enzyme Linked Immuno-Sorbent Assay (ELISA):
      • Based on the specific antigen-antibody interaction principle.
      • Detects disease either through identifying pathogen-specific surface antigens (proteins, glycoproteins) or through measuring host antibodies produced against the pathogen.

Transgenic Animals

  • Definition: Animals whose genome has been modified to stably integrate and express foreign heterologous genes.
  • Species Profile: Transgenic varieties of rats, rabbits, pigs, sheep, cows, and fish have been successfully generated. However, over 95% of all existing transgenic laboratory animals are mice.
  • Primary Applications and Uses:
    1. Study of Normal Physiology and Development:
      • Allows precise investigation of gene regulation and specific biological functions.
      • Example: Transgenic models altering expression of complex growth regulators like insulin-like growth factor reveal its specific physiological roles in vivo.
    2. Study of Human Disease Pathology:
      • Transgenic models are engineered to simulate human genetic pathology to screen novel therapeutic treatments.
      • Transgenic models currently exist for diseases including cancer, cystic fibrosis, rheumatoid arthritis, and Alzheimer's disease.
    3. Production of Biological Products:
      • Transgenic animals act as bioreactors producing valuable human medicinal proteins.
      • Human α\alpha-1-antitrypsin: Gene coding for this protein expressed in animals to produce therapeutics for emphysema management. Similar approaches target phenylketonuria (PKU) and cystic fibrosis.
      • Transgenic Cow Rosie (1997): Produced human protein-enriched milk containing 2.4 g/L2.4\,\text{g/L} (2.4 g L−12.4\,\text{g L}^{-1}) of the human protein alpha-lactalbumin, offering a nutritionally balanced product for human infants compared to natural bovine milk.
    4. Vaccine Safety Testing:
      • Transgenic mice are developed as model systems to evaluate vaccine safety prior to human clinical trials.
      • Used to test batch safety of the oral polio vaccine, replacing the historical reliance on non-human primates (monkeys).
    5. Chemical and Toxicity Safety Testing:
      • Transgenic lines are engineered to carry specific genes conferring heightened sensitivity to toxic substances compared to wild-type animals.
      • Exposure to toxins yields precise safety and toxicity profiles in significantly reduced timeframes.

Ethical Issues and Biopiracy

Ethical Regulation and Oversight

  • Necessity for Regulation: Unregulated genetic manipulation of living organisms poses unpredictable ecological risks upon environmental release.
  • Genetic Engineering Approval Committee (GEAC):
    • An Indian governmental regulatory body.
    • Responsibilities: Evaluates the technical validity of genetic modification research and assesses safety protocols governing the public release of GM organisms and products.

Biopiracy and Patent Controversies

  • Definition of Biopiracy: The unauthorized commercial utilization of biological resources and traditional genetic knowledge by multinational corporations or foreign entities without proper authorization or equitable compensatory payment to indigenous communities and native countries.
  • Resource Asymmetry: Industrialized nations typically possess advanced financial and technological capacity but are poor in indigenous biodiversity and traditional knowledge. Developing and undeveloped nations possess immense biological diversity and rich traditional knowledge systems.
  • Case Study: Basmati Rice Patent:
    • An estimated 200,000 distinct varieties of rice exist in India alone, representing one of the richest global reserves.
    • India has 27 documented, distinct varieties of traditional Basmati rice, renowned for unique aroma and flavor across centuries of historical literature and folklore.
    • In 1997, an American corporate entity secured a patent on Basmati rice through the US Patent and Trademark Office.
    • The patent claimed creation of a 'new' Basmati variety derived by crossing traditional Indian farmer varieties with semi-dwarf lines.
    • The broad patent claims encompassed functional equivalents, restricting third parties from selling Basmati rice commercially.
  • Patent Exploitation of Traditional Herbal Knowledge: Foreign patent applications continuously target traditional Indian remedies including uses of turmeric and neem.
  • Legislative Responses:
    • Nations are constructing statutory legal frameworks to block biopiracy and enforce equitable benefit sharing.
    • The Indian Parliament enacted the Second Amendment of the Indian Patents Bill, addressing patent timelines, statutory research exemptions, emergency provisions, and protection of bio-resources.

Questions & Discussion

  • Which part of the plant is best suited for making virus-free plants and why?
    • Response: The meristem (both apical and axillary) is best suited. Even when an entire plant is systemically infected with a virus, the meristem remains completely free of virus particles. Culturing meristematic tissue in vitro regenerates healthy, virus-free plants.
  • What is the major advantage of producing plants by micropropagation?
    • Response: It allows for the rapid mass propagation of thousands of genetically identical plants (somaclones) in very short timeframes within limited space under sterile conditions.
  • What are the primary chemical components of in vitro tissue culture medium?
    • Response: The medium must contain a carbon source (such as sucrose), inorganic salts, vitamins, amino acids, and plant growth regulators (auxins, cytokinins, etc.).
  • Why do crystalline Bt toxins produced by Bacillus thuringiensis not kill the bacterium itself?
    • Response: The toxin is synthesized as an inactive protoxin within the bacterium. It becomes toxic only when solubilized in the alkaline pH environment of an insect's gut.
  • What are transgenic bacteria? Provide an example.
    • Response: Transgenic bacteria are bacterial cells whose DNA has been transformed with a foreign gene sequence via recombinant DNA technology. An example is Escherichia coli transformed with human DNA sequences coding for Insulin Chain A and Chain B to produce human insulin.
  • What are Cry proteins, what organism produces them, and how are they utilized?
    • Response: Cry proteins are crystalline insecticidal protoxin proteins produced by Bacillus thuringiensis. Humans extract and isolate the encoding cry genes and transform crop plants (e.g., Bt cotton, Bt corn) to express built-in pest resistance without applying chemical insecticides.